Finance

Beta
Lists
PBYI:NASDAQ
Puma Biotechnology Inc
$7.17
-0.97%
(-0.070) 1D
$7.17
0.00% (0.00)
After hours
Closed: May 29, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PBYI...
Open
$7.23
High
$7.23
Low
$7.08
Mkt. cap
364.95M
Avg. vol.
264.00K
Volume
205.86K
P/E ratio
15.03
52-wk high
$7.90
52-wk low
$3.03
EPS
$0.48
Beta
1.24
Shares outstanding
50.90M
No. of employees
179
Open
$7.23
High
$7.23
Low
$7.08
Mkt. cap
364.95M
Avg. vol.
264.00K
Volume
205.86K
P/E ratio
15.03
52-wk high
$7.90
52-wk low
$3.03
EPS
$0.48
Beta
1.24
Shares outstanding
50.90M
No. of employees
179
News stories
From sources across the web
Profile
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA. Wikipedia
About Puma Biotechnology Inc
CEO-
Employees179
Founded2007
HeadquartersLos Angeles, California, United States
SectorBiotechnology
Websitepumabiotechnology.com
Last report
May 7, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
-$0.04 / -$0.13
+69.23%beat
Revenue / Est. (USD)
44.81M / 42.00M
+6.70%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
52.44M
54.48M
75.45M
44.81M
Cost of goods sold
12.30M
12.17M
23.13M
10.42M
Cost of revenue
12.30M
12.17M
23.13M
10.42M
Research and development expenses
15.45M
15.91M
16.84M
19.80M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.05M
16.82M
18.38M
18.42M
Operating expense
33.50M
32.73M
35.22M
38.22M
Total operating expenses
45.80M
44.90M
58.35M
48.64M
Operating income
6.64M
9.57M
17.11M
-3.83M
Other non operating income
410.00K
115.00K
143.00K
130.00K
EBT including unusual items
6.16M
9.24M
17.11M
-3.43M
EBT excluding unusual items
6.16M
9.24M
17.11M
-3.43M
Income tax expense
310.00K
399.00K
3.67M
326.00K
Effective tax rate
5.03%
4.32%
21.45%
-9.51%
Other operating expenses
-
-
-
-
Net income
5.86M
8.84M
13.44M
-3.75M
Net profit margin
11.17%
16.23%
17.81%
-8.37%
Earnings per share
0.15
0.21
0.29
-0.04
Interest and investment income
956.00K
1.04M
977.00K
1.00M
Interest expense
-1.84M
-1.49M
-1.12M
-731.00K
Net interest expenses
-881.00K
-445.00K
-142.00K
271.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
9.40M
12.30M
18.96M
-1.24M
Gain or loss from assets sale
-
-
4.00K
6.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer